Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Gabriel Trova Cuba

Brazil
Publications

A Review of Real-World Use of Ceftazidime-avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections

The incidence of multidrug-resistant-Gram negative bacilli (MDR-GNB) infections is increasing. Ceftazidime-avibactam (CAZ-AVI) is recommended as one of the preferred agents for the treatment of infections caused by carbapenem-resistant Enterobacterales (CRE) or Pseudomonas aeruginosa with Difficult-To-Treat Resistance (DTR-PA). Given the rising thr... Read More»

Ana C. Gales, Luis Fernando Aranha Carmargo, Gabriel Trova Cuba, Felipe Francisco Tuon, Hui Hwa Choo, Maria Lavinea Novis de Figueiredo, Alvaro Quintana and Paurus Mehelli Irani

: J Infect Dis Ther

10.4172/2332-0877.1000483

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top